Igor Matushansky - 01 Feb 2022 Form 4 Insider Report for HOOKIPA Pharma Inc. (HOOK)

Role: Chief Medical Officer
Signature: /s/ Reinhard Kandera, as Attorney-in-Fact
Issuer symbol: HOOK
Transactions as of: 01 Feb 2022
Net transactions value: +$119,463
Form type: 4
Filing time: 01 Feb 2022, 19:49:32 UTC
Previous filing: 12 Jan 2022
Next filing: 20 Apr 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HOOK	Common Stock	Award	$44,799	+14,933	+18%	$3.00	100,240	01 Feb 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HOOK	Stock Option (Right to Buy)	Award	$74,664	+24,888		$3.00	24,888	01 Feb 2022	Common Stock	24,888	$1.50	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person was awarded 14,933 unrestricted shares of common stock as a portion of their base salary for the six month ending June 30, 2022.
F2	This stock option is fully vested.